These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 3913939)
1. [Role of adrenergic receptors in the regulation of lipolysis and in the pathogenesis of obesity]. Kucio C; Zahorska-Markiewicz B Pol Tyg Lek; 1985 Dec; 40(50):1411-4. PubMed ID: 3913939 [No Abstract] [Full Text] [Related]
2. A1 adenosine receptor: role in diabetes and obesity. Dhalla AK; Chisholm JW; Reaven GM; Belardinelli L Handb Exp Pharmacol; 2009; (193):271-95. PubMed ID: 19639285 [TBL] [Abstract][Full Text] [Related]
3. Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Large V; Arner P Diabetes Metab; 1998 Nov; 24(5):409-18. PubMed ID: 9881238 [TBL] [Abstract][Full Text] [Related]
4. [Nutritional factors in obesity, diabetes and arteriosclerosis]. Grande Covián F Rev Med Univ Navarra; 1979 Mar; 23(1):33-7. PubMed ID: 552110 [No Abstract] [Full Text] [Related]
5. Overview of human obesity and central mechanisms regulating energy homeostasis. Crowley VE Ann Clin Biochem; 2008 May; 45(Pt 3):245-55. PubMed ID: 18482911 [TBL] [Abstract][Full Text] [Related]
6. [Adrenergic lipolysis in human fat cells: properties and physiological role of alpha-adrenergic receptors (author's transl)]. Berlan M; Lafontan M; Dang Tran L J Physiol (Paris); 1980; 76(2):133-46. PubMed ID: 6249915 [TBL] [Abstract][Full Text] [Related]
7. Unravelling the mystery of obesity. Garrow J Practitioner; 1997 May; 241(1574):247-50. PubMed ID: 9218400 [No Abstract] [Full Text] [Related]
8. [Hyperglycemic hormones and somatostatin in glycoregulation]. Oliver C; Codaccioni JL Journ Annu Diabetol Hotel Dieu; 1984; ():235-51. PubMed ID: 6152664 [No Abstract] [Full Text] [Related]
10. Regulation of lipolysis and lipoprotein lipase after weight loss in obese, postmenopausal women. Berman DM; Nicklas BJ; Ryan AS; Rogus EM; Dennis KE; Goldberg AP Obes Res; 2004 Jan; 12(1):32-9. PubMed ID: 14742840 [TBL] [Abstract][Full Text] [Related]
11. Obestatin, obesity and diabetes. Ren AJ; Guo ZF; Wang YK; Lin L; Zheng X; Yuan WJ Peptides; 2009 Feb; 30(2):439-44. PubMed ID: 18992781 [TBL] [Abstract][Full Text] [Related]
12. Assays of adrenergic receptors. Including lipolysis and binding measurements. Carpéné C Methods Mol Biol; 2001; 155():129-40. PubMed ID: 11293065 [No Abstract] [Full Text] [Related]
14. [The role of beta 3-adrenergic receptors in the human organism]. Zdrojewicz Z; Sztuka-Pietkiewicz A Przegl Lek; 2001; 58(7-8):788-91. PubMed ID: 11769388 [TBL] [Abstract][Full Text] [Related]
15. Diabetes, obesity, and the brain. Schwartz MW; Porte D Science; 2005 Jan; 307(5708):375-9. PubMed ID: 15662002 [TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis of functional protein sequences reveals a role for brain-derived neurotrophic factor in obesity and type 2 diabetes mellitus. Rao AA; Sridhar GR; Srinivas B; Das UN Med Hypotheses; 2008; 70(2):424-9. PubMed ID: 17553627 [TBL] [Abstract][Full Text] [Related]
17. The obesity epidemic: looking in the mirror. Kumanyika SK Am J Epidemiol; 2007 Aug; 166(3):243-5. PubMed ID: 17575305 [No Abstract] [Full Text] [Related]
18. Fatty acid metabolism in obesity and type 2 diabetes mellitus. Blaak EE Proc Nutr Soc; 2003 Aug; 62(3):753-60. PubMed ID: 14692611 [TBL] [Abstract][Full Text] [Related]
19. A teleological view of obesity, diabetes and hypertension. Landsberg L Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):863-7. PubMed ID: 16922822 [TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine deregulation of food intake, adipose tissue and the gastrointestinal system in obesity and metabolic syndrome. Garruti G; Cotecchia S; Giampetruzzi F; Giorgino F; Giorgino R J Gastrointestin Liver Dis; 2008 Jun; 17(2):193-8. PubMed ID: 18568142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]